Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCV/HIV Coinfection Study
2004-004848-45Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- Jan 2005
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of interferon alfa and ribavirin in hepatitis C virus infection and human immunodeficiency virus infection (HIV) (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Virologic relapse rate at follow-up. Started Jan 2005; status: completed.
02
Drugs
interferon alfaribavirin
03
Conditions
hepatitis C virus infectionhuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2004-004848-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004848-45.